|
2. Florez JC, Manning AK, Dupuis J, Gianniny
L, Irenze K, McAteer J, Mirel DB, Fox CS, Cupples
LA, Meigs JB. A 100K genome-wide association scan
for diabetes and related traits in the Framingham
Heart Study: Replication and integration with
other genome-wide datasets. Diabetes
2007;56: 3063 -3074.
3. The Diabetes Genetics Initiative of Broad
Institute of Harvard and MIT, Lund University
and Novartis Institutes for BioMedical Research.
Genome-wide association analysis identifies loci
for type 2 diabetes and triglyceride levels. Science
2007;316:1331-1336.
4. Florez JC, Jablonski KA, Sun MW, Kahn SE,
Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler
D for the Diabetes Prevention Program Research
Group. Effects of the type 2 diabetes-associated
missense polymorphism PPARG P12A on progression
to diabetes and response to troglitazone. J
Clin Endocrinol Metab 2007;92:1502-1509.
5. Florez JC, Jablonski KA, Kahn SE, Franks PW,
Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler
D for the Diabetes Prevention Program Research
Group. The diabetes-associated missense polymorphisms
KCNJ11 E23K and ABCC8 A1369S
influence progression to diabetes and response
to interventions in the Diabetes Prevention Program.
Diabetes 2007;56:531-536.
6. Florez JC. The new type 2 diabetes gene TCF7L2.
Curr Opin Clin Nutr Metab Care 2007;10:391-396.
7. Florez JC, Jablonski KA, Bayley N, Pollin
TI, de Bakker PIW, Shuldiner AR, Knowler WC, Nathan
DM, Altshuler D, for the Diabetes Prevention Program
Research Group: TCF7L2 polymorphisms
and progression to diabetes in the Diabetes Prevention
Program. N Engl J Med 2006;355:241-250.
For Pubmed Bibliography: click
here
|
|
